Sequential Treatment of Metastatic Colorectal Cancer in Taiwan: Real‐World Evidence From Regorafenib and Trifluridine/Tipiracil Use
The findings indicated that initiating treatment with regorafenib followed by FTD-TPI had superior clinical outcomes compared with the reverse sequence among mCRC patients. This study offers real-world evidence for clinical decision-making and treatment optimization.
Authors
- Chia‐Lun Chang (ORCID: https://orcid.org/0000-0002-2597-0842)
- Chun‐Nan Kuo
- Yu Ko (ORCID: https://orcid.org/0000-0003-4199-0867)
- Jason C. Hsu (ORCID: https://orcid.org/0000-0003-2997-2404)
- Ya‐Wen Chang
Institutions
- Taipei Medical University Hospital (TW)
- Wan Fang Hospital (TW)
- Taipei Medical University (TW)
Publication Details
- Journal
- Journal of Gastroenterology and Hepatology
- Published
- 2025-02-23
- DOI
- https://doi.org/10.1111/jgh.16909
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00